Fluzone Intradermal Vaccine
Fluzone Intradermal vaccine was recently approved by the FDA as the first intradermal flu vaccine in the United States. The needle is very thin (only 1.5 mm long) and only penetrates the skin, unlike the traditional flu vaccine that is given intramuscularly. Fluzone is only approved for adults 18-64. Other vaccines are available for children and persons over 65. Fluzone Intradermal is a Pregnancy Category B (FDA).Other vaccines available include: (1)
Trivalent flu vaccine protects against two influenza A viruses (an H1N1 and an H3N2) and an influenza B virus. The following trivalent flu vaccines are available:
∑ Standard-dose trivalent shots(IIV3) that are manufactured using virus grown in eggs. Different flu shots are approved for people of different ages, but there are flu shots that are approved for use in people as young as 6 months of age and up.
∑ A high-dose trivalent shot, approved for people 65 and older.
∑ A trivalent shot containing virus grown in cell culture, which is approved for people 18 and older, grown in mammalian cells instead of henís eggs.
∑ A recombinant trivalent shot that is egg-free, approved for people 18 through 49 years of age.
Quadrivalent flu vaccine protects against two influenza A viruses and two influenza B viruses. The following quadrivalent flu vaccines are available:quadrivalent nasal spray vaccine, approved for people 2 through 49 years of age (recommended preferentially for healthy* children 2 years through 8 years old when immediately available and there are no contraindications or precautions).
For more information:
FDA - http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM305080.pdf
CDC - http://www.cdc.gov/flu/protect/vaccine/qa_intradermal-vaccine.htm